Apposite Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Apposite Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 1, 2014	Bird Rock Bio	$15.0M Series B	—	5AM Ventures, Bain Capital Life Sciences, INKEF Capital, Longwood Fund, OrbiMed, SR One, The Column Group, Aravis, GlaxoSmithKline, M Ventures, Versant Ventures
Nov 6, 2012	Ambit Pharmaceuticals	$25.0M Other Equity	David Bonita	Aisling Capital, Forward Ventures, Gimv, GrowthWorks, MedImmune Ventures, Radius Ventures, Roche Ventures
Jun 10, 2011	Ambit Pharmaceuticals	$30.0M Series D	Allan Marchington	Forward Ventures, Genechem, Gimv, GrowthWorks, Horizon Technology Finance, MedImmune Ventures, NovaQuest Capital Management, OrbiMed, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche
Feb 1, 2011	Ulthera	$11.0M Series C	New Enterprise Associates	Questa Capital, Vensana Capital
Oct 1, 2010	Convergence Pharmaceuticals	$35.0M Series A	—	Access Biotechnology, Liam Ratcliffe, SV Health Investors
Nov 1, 2007	Ambit Biosciences	$49.0M Series D	—	OrbiMed, Allan Marchington, Avalon Ventures, Standish Fleming, Genechem, Gimv, Horizon Technology Finance, Jov-CMDF, David Mott, NovaQuest Capital Management, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche
Jul 1, 2006	Ambrx	$52.0M Series C	Apposite Capital	Maverick Capital, 5AM Ventures, Aravis, CMEA Capital, Dow Employees Pension Plan, Glynn Capital, Roche, Tavistock Group, Versant Ventures